Cryoport, Inc., a cryogenic logistics company dedicated to the life sciences industry, has launched its ‘Cryoport. Certified. Cool.’ solution, which will be branded as “C³”, to support high value regenerative therapies that require temperature-controlled transportation within the 2 – 8°C temperature range during the logistics of processing these therapies.

The C³ shipper offers 2-8°C shipping and is designed for integration into Cryoport’s informatics platform, the Cryoportal Logistics Management Platform. According to the company, C³ provides enhanced, real-time visibility, security and risk mitigation from temperature excursions for clients critical biological commodities. 
 
Cryoport selected the validated and reusable Credo Cubefrom Pelican BioThermal for its temperature protection, and engineered the Smartpak II Condition Monitoring System, which provides real-time visibility into the location and key aspects of critical shipments and integrates the system into its Cryoportal Logistics Management Platform. The C³  solution includes Cryoport’s 24/7/365 Client Support, which proactively monitors shipments and takes action to mitigate risks when they occur.

Dr. Mark Sawicki, chief commercial officer of Cryoport, said, “The C³ ™ solution was developed in response to recurring requests from our clients who wanted to be able to leverage our trusted Smartpak II™ Condition Monitoring System and our Cryoportal™ Logistics Management Platform to manage their shipments, not only for the cryogenic temperature range, but also in the 2-8°C temperature band. Our new C³ ™ shipper integrates new packaging technology and leverages our cold chain logistics expertise along with our 24/7/365 logistics and client support making Cryoport’s C³ ™ solution the most reliable, groundbreaking 2 – 8°C logistics solution in the life sciences industry.”